Safety and efficacy of abluminal biodegradable polymer sirolimus-eluting coronary stents in patients with acute coronary syndrome: a single-center, prospective, observational trial
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0005187
- Lead Sponsor
- Yonsei University Health System, Yongin Severance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
A patient aged 19 years or older who was diagnosed with acute coronary syndrome and was scheduled for coronary intervention with Genoss stent.
-Patients who voluntarily decided to participate in this study and consented in writing to the subject consent
Exclusion Criteria
- Patients with contraindications or hypersensitivity to antiplatelet therapy
- Life expectancy is less than one year
- Women who are pregnant or wishing to become pregnant or women who are breastfeeding
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rates of 1-year target-lesion failure (composite of cardiac death, target-vessel myocardial infarction [TV-MI], and ischemic-driven target lesion revascularization [ID-TLR])
- Secondary Outcome Measures
Name Time Method The rate of 1-year non-cardiac death;The rate of 1-year non-TV-MI;The rate of 1-year non-ID-TLR;The rate of 1-year cardiac death;The rate of 1-year major adverse cardiac events(MACE) (composite of all-death, all-MI, all-TLR);The rate of 1-year TV-MI;The rate of 1-year ID-TLR;The rate of acute(<24 hr), subacute(<30 day), late(<1 year) stent thrombosis;The success rate of percutaneous coronary intervention